Reviral

Developer of antiviral compounds for RSV

placeLondon, England, United Kingdom calendar_todayFounded 2011 groups28 employees language reviral.co.uk

Registered entities

Investor mix

8 investors on record; lead investors include New Leaf Venture Partners, Novo Holdings; 3 have since exited.

Investor typeCountShare
Venture capital450%
Private equity113%
Bank & private debt113%
Other / undisclosed225%
Coming soon